Prior Stephen David — SEC Form 4 filings

SEC reporting owner CIK 2042268. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-07.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-11-05 to 2026-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AN2 Therapeutics, Inc. (ANTX)Chief Strategy Officer54 legs · 9,256 sh · $10,1004

Form 4 filings — Prior Stephen David

FiledFormIssuerReported transactionsSource
2026-01-074AN2 Therapeutics, Inc. (ANTX)Sale (S): 3,604 @ $1.00 · Sale (S): 2,858 @ $1.01EDGAR
2025-11-064AN2 Therapeutics, Inc. (ANTX)Sale (S): 765 @ $1.14EDGAR
2025-02-284AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 28,000 @ $0 · Grant/award (A): 56,000 (derivative) @ $0EDGAR
2025-01-074AN2 Therapeutics, Inc. (ANTX)Sale (S): 2,029 @ $1.34EDGAR
2024-11-054AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 10,125 @ $0 · Grant/award (A): 20,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2042268 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →